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Opsoclonus-Myoclonus Presenting With Features
of Spasmus Nutans
Spasmus nutans designates an early childhood clinical triad of nys-
tagmus, head nodding, and torticollis.1-11 The head nodding and tilt
are variably present; the nystagmus consists of fine, usually contin-
uous, pendular oscillations, the amplitude of which changes from
moment to moment and usually differs in the two eyes. One eye
may show no oscillations at all.1,3,5,8-10 Initially believed to repre-
sent an idiopathic, self-limited illness lacking other neurologic or
constitutional manifestations, spasmus nutans has recently been
linked to gliomas of the optic nerve and chiasm2,4,5 and hypothala-
mus,10,12,13 ependymoma of the fourth ventricle,2,11 obstructive
hydrocephalus,and Leigh disease.14 In order to point out how
misleading the diagnosis of spasmus nutans may be, we present a
patient who initially manifested a low-amplitude, high-frequency
nystagmus, head nodding, and torticollis and weeks later pro-
gressed to an unmistakable opsoclonus-myoclonus syndrome.
Case Report
An 11-month-old girl developed bilateral otitis media and fever followed
1 week later by head tilt and tremor, irritability, and unsteadiness when
sitting up. The side-to-side head tremor disappeared when she slept. She
was the product of a full-term, normal gestation and normal delivery, and
had no family history of neurologic disease.
Physical examination revealed an irritable but consolable child
with normal vital signs, weighing 8.2 kg (20th percentile) and having a
head circumference of 44.2 cm (20th percentile). Her head, tilted to the
left, shook from side to side intermittently. Both eyes showed small-
amplitude, high-frequency intermittent horizontal, vertical, and oblique
eye movements in all positions of gaze, including straight ahead (prima-
ry) position. Cranial nerve examination was otherwise normal. She had
increased axial and appendicular tone, mild truncal titubation when she
tried to sit, and dysmetria when reaching out for a toy. Deep tendon
reflexes were hyperactive, and plantar reflexes were extensor.
Although the eye movements and torticollis suggested a diagnosis of
spasmus nutans, the presence of other neurologic features impelled a full
evaluation. Computed tomographic and magnetic resonance imaging
scans of the brain were normal, and cerebrospinal fluid was acellular,
with normal chemistries. A 24-hour urine collection revealed vanilmandel-
ic acid, 1.9 mg/total volume (normal, 1 to 1.5 mg); homovanillic acid, 1.4
mg/total volume (normal, 0 to 4 mg); homovanillic acid/creatinine ratio,
17 mg/g of creatinine (normal, < 35 mg/g); epinephrine, 7.0 ug/tota.l volume
(normal, 0 to 5.0 ug); and norepinephrine, 8.0 ug/total volume (normal, 0
to 20 ug). Chest and abdominal computed tomographic and radiolabeled
metaiodobenzylguanidine scan did not show neuroblastoma.
The child’s head tremor worsened over the ensuing 2 weeks to the
point of interfering with her sleep. Her parents now noted large involun-
tary eye movements, increasing unsteadiness, and rapid jerking of the
extremities that interrupted her attempts at feeding. Examination
showed rapid, continuous horizontal, vertical, and oblique conjugate eye
movements of much higher amplitude than weeks earlier-features typi-
cal of opsoclonus. She manifested appendicular and truncal ataxia and
frequent myoclonic jerks involving all extremities.
After a 7-day course of 40 units/day of intramuscular adrenocorti-
cotrophic hormone, the amplitude of the eye movements, head tremor,
myoclonus, and ataxia markedly decreased. By 6 weeks after treatment,
she had fully recovered. 
’
Discussion
In our patient, the combination of low-amplitude, high-frequen-
cy nystagmus, head nodding, and torticollis was compatible with
spasmus nutans, but within weeks, the eye movements had
evolved into opsoclonus, a saccadic eye movement disorder
characterized by conjugate excursions of the eyes in any direc-
tion.15 The excursions are arrhythmic, of large amplitude, and
similar in the two eyes. In children, opsoclonus is often associat-
ed with head and trunk oscillation, extremity ataxia, and
myoclonic jerks as a manifestation of an occult neuroblastoma
or a previous viral illness (opsoclonus-myoclonus syndrome, or
dancing eyes-dancing feet).16 A low-amplitude eye movement
disorder such as our patient initially displayed has not been
described in opsoclonus, but one patient did show a diminution
in amplitude after resection of a retroperitoneal neuroblas-
toma.&dquo; Normal individuals may manifest low-amplitude ocular
flutter, a disturbance akin to opsoclonus.18
Our patient’s eye movements did have two features that are
considered uncharacteristic of spasmus nutans: movements of
equal amplitude in the two eyes and movements in more than
one plane. The nystagmus of spasmus nutans is usually horizon-
tal, less commonly vertical, and much less commonly both.
However, these features are difficult to discern in an irritable
infant whose head is shaking. Considering the prominent torti-
collis, a characteristic of spasmus nutans but not opsoclonus-
myoclonus, it is no wonder that examiners strongly considered
the diagnosis of spasmus nutans.
Our case is, as far as we know, the first to link features of
spasmus nutans and opsoclonus-myoclonus. It points out the
difficulty in distinguishing between a fine pendular rhythmic
ocular oscillation and a nonrhythmic saccadic intrusion and sug-
gests the possibility that they have a common generator. It also
serves as a reminder that the proper classification of spasmus
nutans remains in doubt. The typical pattern of uniplanar sinu-
soidal (pendular) oscillations with varying rhythms and dissoci-
ated amplitudes and frequencies in the two eyes has been
described both as an apparently isolated phenomenon and as a
manifestation of tumors, infections, and developmental abnor-
malities of the central nervous system. Neither the clinical nor
the electronystagmographic examination can distinguish
between the benign, isolated condition (&dquo;pure&dquo; spasmus nutans)
and that associated with other neurologic manifestations.2 Curi-
ously, this eye movement abnormality is quite different from
that found in most acquired disorders affecting the brain stem in
childhood, which typically cause either (1) a jerk nystagmus in
side and upgaze and no nystagmus in the straight ahead (primary) 
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position or (2) circular or oval pendular oscillations (as in
Pelizaeus-Merzbacher diseasel9 and multiple sclerosis2o,2’).
We suggest that spasmus nutans be considered not a diag-
nostic entity, but a manifestation of a brainstem disturbance
with manifestations sometimes not readily appreciated because
of the difficulty of examining a small child or until the disease
evolves. Thorough, repeated clinical examination and brain
imaging are appropriate.
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Baclofen in the Treatment of Polymyoclonus
in a Patient With Unverricht-Lundborg Disease
Unverricht-Lundborg disease is characterized by progressive
ataxia, polymyoclonus, seizures, and intellectual deterioration.1It
was first described by Unverricht in 1891. Lundborg, Unverricht’s
student, reported 50 similar cases in 30 families in 1903.2 Valproic
acid and/or clonazepam have been reported to be effective in
ameliorating the polymyoclonus and seizures seen in Unverricht-
Lundborg disease.3-6 In our patient, however, these drugs were
ineffective in modifying the polymyoclonus and ataxia.
Case Report
A.B. is a 15-year-old right-handed girl who was born in Poland after a full-
term gestation followed by a normal spontaneous vaginal delivery. She
walked at 14 months and spoke in phrases by 25 months. At 3 years of
age, she had a generalized seizure with fever. She recovered sponta-
neously, and no treatment was prescribed. At 4 years of age, she devel-
oped an ataxic gait, which became progressively worse. By age 5 years,
her parents had noted mental deterioration and slurred speech. Intention
polymyoclonus was first noted at age 6 years. All of her symptoms deteri-
orated, so that by age 11 years she was wheelchair bound and was
unable to feed herself. Her father had to pick her up to move her from
place to place. She was withdrawn and depressed, and her speech had
become totally unintelligible.
The family emigrated to the United States in November 1992, when
the patient was 15 years old. Two weeks later, on November 24th, she
was admitted to Bellevue Hospital. On admission, she was taking etho-
suximide 250 mg qid, vitamin B12, valproic acid 250 mg tid, and clon-
azepam 2 mg tid. She was having four or five generalized and myoclonic
seizures per day. General physical examination was normal. There was
no hepatomegaly. Neurologic examination revealed a depressed child
strapped into a wheelchair. Although she made sounds, her speech was
unintelligible, and she did not follow commands even when given by her
parents. At rest, there was titubation and constant diffuse polymy-
oclonus made worse by intention. She was able to hold a pencil with a
palmar grasp, and her drawing and handwriting were unintelligible (Fig-
ure lA). Hypertonia was present in all four extremities. Deep tendon
reflexes were increased throughout. However, toes were bilaterally
down-going. She had severe truncal and appendicular ataxia made worse
with intention.
Work-up including complete blood count, sequential multiple analy-
sis-7, Mug’+, P04, liver function tests, lactic acid, analysis of cerebrospinal
fluid (white blood cells, protein, glucose, lactate, and pyruvate), carnitine
(total and free), vitamin E, serum a-tocopherol, rubeola immunoglobulin
G, and blood and urine organic amino acids produced normal results.
Skin biopsy for Lafora bodies and neuronal ceroid lipofuscinosis was nor-
mal. Electron microscopy showed normal mitochondria architecture.
Studies for GMI, GM2, and a-(N)-neuraminidase were normal. Head com-
puted tomographic scan with contrast, electromyogram, and brainstem
auditory evoked responses were normal. Electroencephalogram showed
diffuse slowing with occasional parasagittal spikes. Visual evoked
response showed abnormal P100 waves bilaterally. Ethosuximide and vit-
amin B12 were discontinued, with no change in her clinical status. Her val-
proic acid level was 85 pg/mL on 250 mg tid. The valproic acid dosage was
raised to 500 mg tid, with a blood level of 120 pg/mL and no change in her
clinical status. In order to attempt to decrease hypertonia and spasticity,
baclofen 40 mg/day was added and gradually increased to 150 mg/day.
Polymyoclonus and ataxia were significantly decreased, as was the spas-
ticity and hypertonia. This resulted in a remarkable improvement in her
clinical condition, so that she is now able to stand alone, walk holding on
with one hand, climb steps, and turn while walking. She can throw and
catch a ball and go on a swing and move it without assistance. She can
draw pictures (Figure 1B), write legibly (Figure 2), use scissors, and feed
herself. Speech is now intelligible, with a higher than expected cognitive
level. She is outgoing and happy. Seizure frequency has decreased from
four or five per day to one per week. This improvement has been sus-
tained for 16 months to date.
